Etiology-independent activation of the LTβ-LTβR-RELB axis drives aggressiveness and predicts poor prognosis in HCC
Anna-Lena Scherr,Luisa Nader,Kaiyu Xu,Christin Elssner,Dirk A Ridder,Federico Nichetti,Manuel Mastel,Sarah Fritzsche,Eblina Kelmendi,Nathalie Schmitt,Paula Hoffmeister-Wittmann,Sofia M E Weiler,Felix Korell,Thomas Albrecht,Maximilian Schwab,Hanna Isele,Annika Kessler,Jennifer Hüllein,Agnieszka Seretny,Liangtao Ye,Toni Urbanik,Stefan Welte,Anne-Laure Leblond,Christoph E Heilig,Mohammad Rahbari,Adnan Ali,Suchira Gallage,Bénédicte Lenoir,Nina Wilhelm,Ulrike Gärtner,Simon J Ogrodnik,Christoph Springfeld,Darjus Tschaharganeh,Stefan Fröhling,Thomas Longerich,Henning Schulze-Bergkamen,Dirk Jäger,Lydia Brandl,Peter Schirmacher,Beate K Straub,Achim Weber,Enrico N De Toni,Benjamin Goeppert,Mathias Heikenwalder,Rene Jackstadt,Stephanie Roessler,Kai Breuhahn,Bruno C Köhler
DOI: https://doi.org/10.1097/HEP.0000000000000657
IF: 17.298
2024-08-01
Hepatology
Abstract:Background and aims: HCC is the most common primary liver tumor, with an increasing incidence worldwide. HCC is a heterogeneous malignancy and usually develops in a chronically injured liver. The NF-κB signaling network consists of a canonical and a noncanonical branch. Activation of canonical NF-κB in HCC is documented. However, a functional and clinically relevant role of noncanonical NF-κB and its downstream effectors is not established. Approach and results: Four human HCC cohorts (total n = 1462) and 4 mouse HCC models were assessed for expression and localization of NF-κB signaling components and activating ligands. In vitro , NF-κB signaling, proliferation, and cell death were measured, proving a pro-proliferative role of v-rel avian reticuloendotheliosis viral oncogene homolog B (RELB) activated by means of NF-κB-inducing kinase. In vivo , lymphotoxin beta was identified as the predominant inducer of RELB activation. Importantly, hepatocyte-specific RELB knockout in a murine HCC model led to a lower incidence compared to controls and lower maximal tumor diameters. In silico , RELB activity and RELB-directed transcriptomics were validated on the The Cancer Genome Atlas HCC cohort using inferred protein activity and Gene Set Enrichment Analysis. In RELB-active HCC, pathways mediating proliferation were significantly activated. In contrast to v-rel avian reticuloendotheliosis viral oncogene homolog A, nuclear enrichment of noncanonical RELB expression identified patients with a poor prognosis in an etiology-independent manner. Moreover, RELB activation was associated with malignant features metastasis and recurrence. Conclusions: This study demonstrates a prognostically relevant, etiology-independent, and cross-species consistent activation of a lymphotoxin beta/LTβR/RELB axis in hepatocarcinogenesis. These observations may harbor broad implications for HCC, including possible clinical exploitation.